[HTML][HTML] Elexacaftor-Tezacaftor-Ivacaftor: a life-changing triple combination of CFTR modulator drugs for cystic fibrosis
M Bacalhau, M Camargo, GAV Magalhães-Ghiotto… - Pharmaceuticals, 2023 - mdpi.com
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
M Bacalhau, M Camargo… - …, 2023 - search.proquest.com
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
M Bacalhau, M Camargo… - Pharmaceuticals …, 2023 - pubmed.ncbi.nlm.nih.gov
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis.
M Bacalhau, M Camargo… - Pharmaceuticals …, 2023 - europepmc.org
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis.
M Bacalhau, M Camargo… - Pharmaceuticals …, 2023 - search.ebscohost.com
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
[HTML][HTML] Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
M Bacalhau, M Camargo… - …, 2023 - ncbi.nlm.nih.gov
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
[引用][C] Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
M Bacalhau, M Camargo, GAV Magalhães-Ghiotto… - …, 2023 - europepmc.org
Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …
multisystemic pathology. Over the last decade, the introduction of CF transmembrane …